Tenax Therapeutics (TENX) Finished Goods (2012 - 2014)

Tenax Therapeutics (TENX) reported Finished Goods of $68658.0 for Q1 2014, down 13.27% on a YoY basis from $79159.0 in Q1 2013, and down 0.79% sequentially from $69206.0 in Q4 2013.

Tenax Therapeutics (TENX) Finished Goods (2012 - 2014) Analysis & Trends

Tenax Therapeutics (TENX) has 3 years of Finished Goods data on file, last reported at $68658.0 in Q1 2014.

  • For the quarter ending Q1 2014, Finished Goods fell 13.27% year-over-year to $68658.0; the trailing twelve-month figure through Jan 2014 stood at $68658.0 (down 13.27% YoY), and the FY2013 full-year result was $70425.0, up 21.86% from the prior year.
  • Finished Goods retreated to $68658.0 in Q1 2014, from $69206.0 in the prior quarter.
  • In the past five years, Finished Goods ranged from a high of $80578.0 in Q4 2012 to a low of $49480.0 in Q3 2012.
  • A 3-year average of $68181.8 and a median of $69681.5 in 2013 frame the typical range for Finished Goods.
  • Peak annual rise in Finished Goods reached 41.79% in 2013, while the deepest fall reached 14.11% in 2013.
  • Tracing TENX's Finished Goods over 3 years: stood at $80578.0 in 2012, then retreated by 14.11% to $69206.0 in 2013, then declined by 0.79% to $68658.0 in 2014.
  • Business Quant data shows TENX's Finished Goods at $68658.0 in Q1 2014, $69206.0 in Q4 2013, and $70157.0 in Q3 2013.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Tenax Therapeutics 67,856.40 67,856.40 -

Historic Data

Download Data
DateValue
Jan 31, 2014 68,658.00
Oct 31, 2013 69,206.00
Jul 31, 2013 70,157.00
Apr 30, 2013 70,425.00
Jan 31, 2013 79,159.00
Oct 31, 2012 80,578.00
Jul 31, 2012 49,480.00
Apr 30, 2012 57,791.00